The goal of this proposal is to validate the misregulation of Tau in ARSACS and establish a platform from which to explore therapeutic targeting of proteins involved in tau pathology as a treatment for ARSACS.
Grant : $98,758
Dr. Anthony Hickey, Director of UNC Catalyst for Rare Diseases, University of North Carolina
120 Mason Farm Road CB# 7356, Chapel Hill NC 27599
Tel: (919) 962-9819